Two Sigma Advisers’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Two Sigma Advisers's ADPT Position: Q1 2026 in Review
Two Sigma Advisers sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 128,100 shares — an estimated $2.08M sold.
Two Sigma Advisers first reported a position in ADPT in Q1 2021 and held it in 14 quarters. The position peaked at $2.08M in Q4 2025. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Two Sigma Advisers reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 128,100 Adaptive Biotechnologies shares in Q1 2026, an estimated $2.08M.
- Two Sigma Advisers first reported a position in Adaptive Biotechnologies in Q1 2021 and held it in 14 quarters.
- Two Sigma Advisers's Adaptive Biotechnologies position peaked at $2.08M in Q4 2025.
- 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.